PropertyValue
?:abstract
  • Large-scale sampling of patient microbiomes is giving one organization the tools to correlate microbiome composition with immune health, driving the deployment of safe, live biotherapeutic treatments for cancer and COVID-19 The role of gut microbes in human health has been recognized for decades, but recent advances in technologies like next-generation sequencing, transcriptomic and proteomic analyses, and metabolic modeling have expanded our understanding of microbiome population dynamics, metabolic activity, and functional interactions with the human body
is ?:annotates of
?:creator
?:journal
  • Chemical_Engineering_Progress
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Developing Precision Microbiome Medicines
?:type
?:who_covidence_id
  • #911167
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ggsdizar>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ggsdizar>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all